About
Karleen M. Oberton is the Chief Financial Officer of Hologic, Inc., a global medical technology company. She brings deep financial advisory, audit and SEC reporting experience as well as extensive global leadership experience at a public company, and is designated an audit committee financial expert. She serves on AMETEK's Audit Committee and will become its Chair as of May 6, 2026.
Roles
Ametek Inc.
Director · Current role
2021–present
Hologic, Inc.
Chief Financial Officer · Joined Hologic in 2006 as Vice President and Corporate Controller; named Corporate Vice President and Chief Accounting Officer in 2014, then elected CFO in 2018.
August 2018 – May 2026
Hologic, Inc.
Corporate Vice President and Chief Accounting Officer
2014 – 2018
Hologic, Inc.
Vice President and Corporate Controller
2006 – 2014
ImmunoGen
Senior Corporate Controller · A biotechnology company developing targeted anticancer therapeutics; earlier held leadership positions at Ernst & Young and Arthur Andersen.
—
Director Compensation
FY 2025
Fees earned or paid in cash
$112,500